Recombinant CA9 (Girentuximab Biosimilar) anticorps

N° du produit ABIN7581268

L’anticorps Human Monoclonal anti-CA9 (Girentuximab Biosimilar) a été validé pour ELISA, FACS, BLI, Func et SPR. Il convient pour détecter CA9 (Girentuximab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant CA9 (Girentuximab Biosimilar) anticorps (ABIN7581268)

Antigène: CA9 (Girentuximab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CA9 (Girentuximab Biosimilar) est non-conjugé

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-CA9 (Girentuximab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CA9 / CAIX Reference Antibody (girentuximab)

Séquence: DVKLVESGGG LVKLGGSLKL SCAASGFTFS NYYMSWVRQT PEKRLELVAA INSDGGITYY LDTVKGRFTI SRDNAKNTLY LQMSSLKSED TALFYCARHR SGYFSMDYWG QGTSVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,DIVMTQSQRF MSTTVGDRVS ITCKASQNVV SAVAWYQQKP GQSPKLLIYS ASNRYTGVPD RFTGSGSGTD FTLTISNMQS EDLADFFCQQ YSNYPWTFGG GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

Attributs du produit: Anti-CA9 / Carbonic anhydrase 9 Reference Antibody (girentuximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: CAIX inhibitors

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur CA9 (Girentuximab Biosimilar)

Antigène: CA9 (Girentuximab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 145.5 kDa

UniProt: Q16790